FHTX
USDFoghorn Therapeutics Inc. Common Stock
$4.360+0.320 (7.921%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$4.040
High
$4.430
Low
$3.860
Volume
0.31M
Company Fundamentals
Market Cap
246.6M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.17M
Exchange
NGM
Currency
USD
52-Week Range
Low $2.945Current $4.360High $9.7
Related News
GlobeNewswire
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (NASDAQ:FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting
View more
GlobeNewswire
Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs
- Data presented at the TPD and Induced Proximity Summit demonstrate that novel Selective ARID1B degrader selectively binds and degrades ARID1B; potentially relevant in up to 5% of all solid tumors - Selective CBP
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.